𝐀𝐈, 𝐂𝐚𝐦𝐛𝐫𝐢𝐝𝐠𝐞, 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 @Cambridge_Uni researchers used AI to accelerate the drug screening process for Parkinson's disease & identified five promising candidates. Parkinson’s disease is believed to be caused by misfolded...⬇️ #AI #research #healthcare
proteins that form aggregates in nerve cells. However, despite its global impact, Parkinson's has no approved #disease-modifying treatments. This research in AI-driven drug discovery offers a faster and more cost-effective approach than traditional methods. #Parkinsons
The #researchers developed a #MachineLearning-based approach to screen millions of chemical compounds and identify those that inhibit #protein aggregation. Then, the iterative screening process of testing the top compounds enables the identification of potent #drug candidates.